Lieto, Finland

Pasi Virta


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Pasi Virta

Introduction

Pasi Virta, an accomplished inventor based in Lieto, Finland, has made notable contributions to the field of biotechnology. His innovative spirit has led to the development of two significant patents that enhance diagnostic and therapeutic methods, showcasing his expertise and dedication to scientific advancement.

Latest Patents

Pasi Virta's latest patents include inventions focused on aminooxy functionalized oligomers and oligomer arrays. The present inventions provide oligomers specifically hybridizable with selected sequences of RNA or DNA, where at least one of the nucleoside moieties is modified to include an aminooxy linkage. These oligomers are designed to be useful for various diagnostic, therapeutic, and investigative purposes, highlighting their importance in the realm of molecular biology.

Career Highlights

Pasi Virta is currently affiliated with Isis Pharmaceuticals, Inc., a company known for its pioneering work in genetic medicine and RNA-targeted therapeutics. His role at the company has allowed him to further develop his ideas and collaborate with other brilliant minds in the field.

Collaborations

Throughout his career, Pasi has collaborated with esteemed colleagues such as Muthiah Manoharan and Harri Lonnberg. These partnerships have fostered an environment of innovation and have been instrumental in driving forward the groundbreaking research that leads to new inventions and patents.

Conclusion

Pasi Virta’s contributions to the biotechnology sector, particularly through his patents on aminooxy functionalized oligomers, embody the essence of innovation. His work not only reflects his creativity and technical expertise but also significantly impacts the future of diagnostic and therapeutic procedures. As he continues to collaborate with other leaders in the industry, the potential for further advancements remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…